News Agency
The Times

Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report

  • Written by PR Newswire
Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report
  • Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins
  • Regulatory approval from the U.K. and Italian regulatory agencies to proceed with the Phase 2 trial
  • A$4.1 million R&D Tax Incentive Scheme refund
  • Cash balance on 30 June 2022 of A$34.8M

MELBOURNE, Australia and SAN FRANCISCO, July 22, 2022 /PRNewswire/...

Read more: Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion